Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Evaluating the Utility of Ultrasound Confirmed Enthesitis as a Prognostic Marker for Response to Biologic Therapy in Psoriatic Arthritis

NCT03955861 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.

NCT NCT03955861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03955861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Evaluating the Utility of Ultrasound Confirmed Enthesitis as a Prognostic Marker for Response to Biologic Therapy in Psoriatic Arthritis
Lead sponsor
Belfast Health and Social Care Trust
Phase
Observational
Overall status
Completed
Start date
February 14, 2019
Completion date
July 17, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enthesitis, psoriasis, psoriatic arthritis